BFC Planning’s Rentokil RTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$890 Buy
45
+1
+2% +$25 ﹤0.01% 3186
2026
Q2
$1.26K Buy
44
+6
+16% +$190 ﹤0.01% 3098
2026
Q1
$1.2K Hold
38
– – ﹤0.01% 2710
2025
Q4
$1.12K Buy
38
+6
+19% +$167 ﹤0.01% 2766
2025
Q3
$808 Sell
32
-30
-48% -$731 ﹤0.01% 2671
2025
Q2
$1.49K Hold
62
– – ﹤0.01% 2375
2025
Q1
$1.42K Hold
62
– – ﹤0.01% 2380
2024
Q4
$1.57K Sell
62
-205
-77% -$5.2K ﹤0.01% 2339
2024
Q3
$6.66K Buy
+267
New +$7.91K ﹤0.01% 1909

Other funds holding RTO

BFC Planning's RTO Position: Q3 2026 in Review

BFC Planning increased its Rentokil (RTO) stake by 2.3% in Q3 2026, buying an estimated $25 and bringing the position to 45 shares worth $890. The position accounts for ﹤0.01% of the portfolio, ranked #3186.

BFC Planning first reported a position in RTO in Q3 2024 and has held it in 9 quarters since. The position peaked at $6.66K in Q3 2024. 204 funds tracked by Wall St. Rank hold RTO as of Q3 2026.

  • BFC Planning held 45 shares of Rentokil worth $890 as of Q3 2026.
  • BFC Planning bought 1 Rentokil share in Q3 2026, an estimated $25.
  • Rentokil made up ﹤0.01% of BFC Planning's portfolio in Q3 2026, its #3186 holding.
  • BFC Planning first reported a position in Rentokil in Q3 2024 and has held it in 9 quarters since.
  • BFC Planning's Rentokil position peaked at $6.66K in Q3 2024.
  • 204 funds tracked by Wall St. Rank held Rentokil as of Q3 2026.

Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.